GUTS (STOCKS)
Fractyl Health, Inc. Common Stock
$0.850000
+0.000000 (+0.00%)
Prev close: $0.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Harith Rajagopalan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $135.03M
- Employees
- 109
- P/E (TTM)
- -0.57
- P/B (TTM)
- 6.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.13 | $-0.16 | +0.0332 | +20.34% |
|
Dec 2025 (Q4)
|
$-0.07 | $-0.18 | +0.1136 | +61.87% |
|
Sep 2025 (Q3)
|
$-0.71 | $-0.32 | -0.3877 | -120.29% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.37 | -0.2028 | -55.23% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$15.12M |
| Operating Expenses | $92.88M |
| Selling, General, and Administrative Expenses | $22.18M |
| Research and Development | $70.70M |
| Operating Income/Loss | -$92.88M |
| Income/Loss From Continuing Operations After Tax | -$108.00M |
| Income/Loss From Continuing Operations Before Tax | -$108.00M |
| Net Income/Loss | -$108.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$108.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$108.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.29 |
| Diluted Earnings Per Share | -$1.29 |
| Basic Average Shares | 293,764,485 |
| Diluted Average Shares | 293,764,485 |
| Assets | $99.39M |
| Current Assets | $65.92M |
| Noncurrent Assets | $33.47M |
| Fixed Assets | $2.13M |
| Other Non-current Assets | $31.34M |
| Liabilities | $78.01M |
| Current Liabilities | $15.41M |
| Accounts Payable | $1.65M |
| Other Current Liabilities | $13.76M |
| Noncurrent Liabilities | $62.60M |
| Equity | $21.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $21.38M |
| Liabilities And Equity | $99.39M |
| Net Cash Flow From Operating Activities | -$87.73M |
| Net Cash Flow From Operating Activities, Continuing | -$87.73M |
| Net Cash Flow From Investing Activities | $18.26M |
| Net Cash Flow From Investing Activities, Continuing | $18.26M |
| Net Cash Flow From Financing Activities | $108.90M |
| Net Cash Flow From Financing Activities, Continuing | $108.90M |
| Net Cash Flow | $39.43M |
| Net Cash Flow, Continuing | $39.43M |
| Comprehensive Income/Loss | -$108.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$108.00M |
| Other Comprehensive Income/Loss | $0.00 |